These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 21920401)
1. A retrospective survey of the safety of trivalent influenza vaccine among adults working in healthcare settings in south metropolitan Perth, Western Australia, in 2010. McEvoy SP Vaccine; 2012 Apr; 30(17):2801-4. PubMed ID: 21920401 [TBL] [Abstract][Full Text] [Related]
3. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Blyth CC; Currie AJ; Wiertsema SP; Conway N; Kirkham LA; Fuery A; Mascaro F; Geelhoed GC; Richmond PC Vaccine; 2011 Jul; 29(32):5107-13. PubMed ID: 21640152 [TBL] [Abstract][Full Text] [Related]
4. Uptake of influenza vaccine by healthcare workers in an acute hospital in Ireland. O'Rorke C; Bourke W; Bedford D; Howell F Ir Med J; 2003; 96(7):207-9. PubMed ID: 14518583 [TBL] [Abstract][Full Text] [Related]
5. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Müller D; Szucs TD Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730 [TBL] [Abstract][Full Text] [Related]
6. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: lessons for improving vaccination rates. Chen SC; Hawkins G; Aspinall E; Patel N Vaccine; 2012 Jan; 30(2):493-7. PubMed ID: 21527302 [TBL] [Abstract][Full Text] [Related]
7. Trial of influenza HA vaccination for healthcare workers in consecutive years. Fujita Y; Okada T; Mugishima H; Kumasaka K; Sawa M; Tachihara S Jpn J Infect Dis; 2009 Nov; 62(6):464-6. PubMed ID: 19934541 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of pandemic influenza A (H1N1) 2009 vaccine in healthcare workers at a university hospital in Japan. Igari H; Watanabe A; Chiba H; Shoji K; Segawa S; Nakamura Y; Watanabe M; Suzuki K; Sato T Jpn J Infect Dis; 2011; 64(3):177-82. PubMed ID: 21617299 [TBL] [Abstract][Full Text] [Related]
9. Co-ordinated approach to healthcare worker influenza vaccination in an area health service. Ballestas T; McEvoy SP; Doyle J; J Hosp Infect; 2009 Nov; 73(3):203-9. PubMed ID: 19783073 [TBL] [Abstract][Full Text] [Related]
10. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):989-92. PubMed ID: 20703207 [TBL] [Abstract][Full Text] [Related]
11. Seasonal influenza vaccination coverage among local health department personnel in North Carolina, 2007-2008. Kent JN; Lea CS; Fang X; Novick LF; Morgan J Am J Prev Med; 2010 Jul; 39(1):74-7. PubMed ID: 20537842 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Szucs TD; Müller D Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035 [TBL] [Abstract][Full Text] [Related]
13. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of adverse events after influenza vaccination in hospital personnel. Scheifele DW; Bjornson G; Johnston J CMAJ; 1990 Jan; 142(2):127-30. PubMed ID: 2295029 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD; Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787 [TBL] [Abstract][Full Text] [Related]
17. The adverse events of influenza A (H1N1) vaccination and its risk factors in healthcare personnel in 18 military healthcare units in Korea. Hwang SM; Choe KW; Cho SH; Yoon SJ; Park DE; Kang JS; Kim MJ; Chun BC; Lee SM Jpn J Infect Dis; 2011; 64(3):183-9. PubMed ID: 21617300 [TBL] [Abstract][Full Text] [Related]
18. Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy). Amodio E; Anastasi G; Marsala MG; Torregrossa MV; Romano N; Firenze A Vaccine; 2011 Feb; 29(7):1408-12. PubMed ID: 21199700 [TBL] [Abstract][Full Text] [Related]
19. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events. Dey A; Gidding HF; Menzies R; McIntyre P Vaccine; 2014 Apr; 32(19):2204-8. PubMed ID: 24613527 [TBL] [Abstract][Full Text] [Related]
20. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]